Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2017, Article ID 3860107, 4 pages
Case Report

Borderline Clear Cell Adenofibroma of the Ovary

Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Correspondence should be addressed to Chumnan Kietpeerakool; moc.liamtoh@ij_teik

Received 31 January 2017; Revised 22 March 2017; Accepted 28 March 2017; Published 30 March 2017

Academic Editor: Yoji Nagashima

Copyright © 2017 Pilaiwan Kleebkaow et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Longacre and M. Wells, “WHO classification of tumours of the ovary,” in World Health Organization Classification of Tumours of Female Reproductive Organs, R. Kurman, M. L. Carcangiu, C. S. Herrington, and R. H. Young, Eds., pp. 12–43, IARC Press, 4th edition, 2014. View at Google Scholar
  2. S. J. Seong, D. H. Kim, M. K. Kim, and T. Song, “Controversies in borderline ovarian tumors,” Journal of Gynecologic Oncology, vol. 26, no. 4, pp. 343–349, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Uzan, M. Dufeu-Lefebvre, R. Fauvet et al., “Management and prognosis of clear cell borderline ovarian tumor,” International Journal of Gynecological Cancer, vol. 22, no. 6, pp. 993–999, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Zhao, L. S.-F. Wu, and R. Barner, “Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development,” Journal of Cancer, vol. 2, no. 1, pp. 94–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Vasilakaki, E. Skafida, E. Arkoumani, X. Grammatoglou, N. Firfiris, and K. Manoloudaki, “Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report,” European Journal of Gynaecological Oncology, vol. 33, no. 2, pp. 230–232, 2012. View at Google Scholar · View at Scopus
  6. E. Cakir, E. Aydin, N. I. Durmus, E. Samdanci, N. Sahin, and Z. Nurkabul, “Primary ovarian clear cell adenofıbroma of borderline malignancy,” Oman Medical Journal, vol. 27, no. 1, 2012. View at Google Scholar
  7. S. M. Vasenwala, H. A. Ansari, N. Haider, S. Rehman, and T. Khan, “Atypical proliferating clear cell adenofibroma of the ovary: a case report,” Middle East Journal of Cancer, vol. 4, no. 2, pp. 87–90, 2013. View at Google Scholar
  8. Ö. Paşaoglu, E. Çiftçi, N. Tel, S. Ozalp, and M. F. Acikalin, “Benign clear cell adenofibroma of the ovary: a case report with literature review,” Gynecologic and Obstetric Investigation, vol. 64, no. 1, pp. 36–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Yamamoto, H. Tsuda, T. Yoshikawa et al., “Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics,” American Journal of Surgical Pathology, vol. 31, no. 7, pp. 999–1006, 2007. View at Publisher · View at Google Scholar · View at Scopus